![]() |
| Terri Clevenger |
Like many of my colleagues, I read Gartner's 2026 CCO Spend Survey and watched the industry celebrate. The emerging interpretation was that earned media budgets would double by 2027 because AI search relies on third-party sources.
That conclusion is convenient. It is also too tactical.
Media relations matters, perhaps more than it has in years. But the answer is not simply more pitching or placements.
AI is exposing something more consequential: the distance between the story a company distributes and the reputation its actions have earned.
For years, healthcare companies built the public record one announcement at a time, controlling the message and timing. Generative AI disrupts that control. It draws from journalism, scientific literature, regulatory documents, patient groups, social platforms and employee commentary. It encounters not one corporate narrative, but a body of evidence.
AI is reading a much broader record
Muck Rack's May 2026 analysis of more than 25 million links cited by generative AI found that 99 percent came from nonpaid sources. About 84 percent fell within its broad definition of earned media, while press releases accounted for just 1.1 percent. Journalism represented about 27 percent. The rest included academic, government, nonprofit, reference and social sources.
That matters, especially in healthcare. An AI-generated answer may draw from a peer-reviewed journal, FDA document, analyst commentary, patient organization, physician interview, conference presentation or employee's LinkedIn post. Companies have less control over which pieces surface and how they are combined.
Press releases still have an essential role. They provide a precise, compliant account of a financing, clinical milestone or regulatory decision. But a company announcement is a first-party assertion. It cannot corroborate itself.
Corroboration comes from scientific scrutiny, regulatory action, stakeholder experience, independent reporting and the company's conduct over time. When those sources reinforce the corporate story, they create credibility. When they contradict it, no volume of content can close the gap. AI simply makes the record easier to assemble and harder to ignore.
| This article is featured in O'Dwyer's October '26 Healthcare PR Magazine |
Reputation begins before the story is told
Consider a typical precommercial biotech. It regularly announces clinical progress, conference presentations, financings and corporate milestones. Those releases are republished across financial platforms, creating an extensive searchable record.
Volume is not credibility. The record may show activity while revealing little about why the science matters, whose needs informed it or whether knowledgeable stakeholders believe in its potential. The company has documented progress without necessarily creating reputational pull.
Dyne Therapeutics offers a different model. Beyond releases and investor presentations, one meaningful part of its record began before any announcement: patient input helped shape its DELIVER and ACHIEVE clinical trials.
That engagement informed the work and was later documented in a peer-reviewed journal. Scientific presentations, disease-community engagement, physician commentary and independent coverage added perspectives, showing science informed by patients and subjected to expert scrutiny.
The release announced the progress. The broader record established what that progress meant and why others should believe it.
Visibility is not validation
Media remains essential because independent reporting adds context, scrutiny and credibility. But the question is no longer simply, "Where can we get covered?" It is, "What does the business need people to understand, what evidence supports it and who has the authority to validate it?"
The answer will not always be the largest outlet. A deeply reported trade story may do more reputational work than a passing national mention. A scientific publication, physician perspective, patient organization or regulatory document may carry even greater authority.
A credible source can influence the record long after publication. Media relations must therefore do more than generate visibility; it should help journalists examine and contextualize what the company wants to be known for.
One company, one story, many credible voices
A broader body of evidence is valuable only if it adds up. Companies need a central narrative that can travel across channels and stakeholders without losing its meaning.
Coherence does not mean sameness. A scientist should not sound like an investor presentation, nor a patient advocate like the corporate website. Each should speak from experience and expertise. When every voice repeats identical language, validation begins to feel orchestrated.
Scientific publications, advocacy, investor relations, executive visibility, employees, owned content, social media and earned coverage contribute different evidence. None can build reputation alone. Each should illuminate and reinforce the larger story.
Employees matter because their decisions and behavior create the experiences on which others judge the company. Narrative alignment must begin inside the organization, where strategy, culture and behavior give people something consistent to experience.
Reputation is also built between newsworthy moments, as leaders explain uncertainty and scientists engage with their communities. A milestone focuses attention. What stakeholders find around it determines what they believe.
Invest where the evidence is weakest
PR agencies may see Gartner's findings as a windfall. If we interpret them simply as a reason to sell more media relations, we will have learned the wrong lesson.
Investment should begin with the business problem. What must the company be trusted to do? What do its stakeholders believe? Where does the record rely almost entirely on corporate assertions?
The gap may be scientific validation, executive visibility, employee experience, patient engagement or an outdated corporate narrative. Media outreach may be part of the answer. So might scientific communications, advocacy, leadership engagement, culture or digital content. Investment should follow the reputational need, not an agency's preferred service.
Communicators can identify the gap, align the story and make evidence easier to find. But communications cannot compensate for a reality that contradicts the narrative. Reputation starts inside the company, with leadership decisions, organizational behavior and the stakeholder experiences they create over time.
A press release can announce the news. A media placement can examine it. Reputation is built when the company's claims, actions and stakeholder experiences hold together wherever people and machines choose to look.
AI does not create a company's reputation. It reveals the one the company has already earned.
***
Terri Clevenger is Head of Integrated Communications, Waterhouse.


To make sure that the messages an annual meeting is supposed to deliver connect with their audiences, focus on the big story behind the complex data.
It’s not enough to simply be a good storyteller. Communicators now need to be explainers—making a range of complex subjects understandable to consumers.
Building awareness is no longer enough. Marketing and communications must ensure that when buyers begin researching a category, the company is visible, credible and differentiated.
With AI facing blowback from many audiences, it is becoming increasingly important to make sure that the human side of your communications comes through.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.



